Tesamorelin

Egrifta

An FDA-approved GHRH analog indicated for the reduction of excess visceral abdominal fat in HIV-associated lipodystrophy.

FDA approved. Approved or legitimately prescribed for at least one indication. Dose information below is reference material, not a recommendation — follow your prescriber and the product labelling.

At a glance

Category: Growth Hormone
Half-life: ~8 minutes
Typical vial sizes: 1 mg · 2 mg
Commonly cited dose: 1000–2000 mcg
Frequency: once daily
Routes: Subcutaneous

A 1 mg vial, worked through.

Reconstituting a 1 mg vial of Tesamorelin with 2 mL of bacteriostatic water gives 0.5 mg/mL. A 1000 mcg dose is then:

200units(2 mL) — about 1 doses per vial

200 units will not fit in a 1 mL syringe (100 units). Use more concentrated mixing, or split the dose.

Storage

Lyophilised (unmixed): Refrigerated per product labelling.
Reconstituted: Use promptly; follow the product labelling.

What people log it against

Outcomes users commonly track alongside this compound. Listing them is not a claim that it produces them.

Visceral fat reduction (approved indication)

Read alongside Tesamorelin

Compounds this one is commonly compared with, combined with, or mistaken for. Listing a pairing is not a suggestion to run them together.

SermorelinPrescription / compoundedBoth GHRH analogues. Tesamorelin is the one with an approved human indication, which is the practical difference between them.

References

Each source below establishes only the specific claim noted with it, last checked 2026-08-13. Dose ranges, frequencies and storage times reflect what circulating protocols commonly state and are not established by these references.

FDA label — EGRIFTA SV (tesamorelin), DailyMed
"Mean elimination half-life (t1/2) of tesamorelin was 8 minutes in healthy subjects after single dose subcutaneous administration of the 1.4 mg of EGRIFTA SV". Was listed as 0.4 h (24 min), roughly 3x the label value; corrected to 0.13 h (8 min).

Run your own numbers

Pick Tesamorelin from the preset list to start from a typical vial.

Your vial

Peptide in vial

As printed on the vial label

Bacteriostatic water added

How much you inject into the vial

Dose you want

mcg

1000 mcg = 1 mg

Syringe size

Start from a peptide

Fills in a common vial size and the low end of commonly cited protocols. Always check against your own vial.

Draw this much

5units

on a 1 mL U-100 insulin syringe

Concentration: 5 mg/mL
Volume: 0.05 mL
Doses in this vial: 40

Keep this vial. VialPal holds the concentration, counts down the doses left in it, and logs the ones you actually took.

VialPal does the arithmetic — it does not tell you what to take. Dose decisions belong between you and a qualified clinician.